Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations-Reference-Cited by-同舟云学术

Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations

Published:2010-05 Issue:5 Volume:115 Page:945-952
ISSN:0029-7844
Container-title:Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Meyer Larissa A.,Anderson Meaghan E.,Lacour Robin A.,Suri Anuj,Daniels Molly S.,Urbauer Diana L.,Nogueras-Gonzalez Graciela M.,Schmeler Kathleen M.,Gershenson David M.,Lu Karen H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference28 articles.

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.;Miki;Science,1994

2. Identification of the breast cancer susceptibility gene BRCA2.;Wooster;Nature,1995

3. Risk models for familial ovarian and breast cancer.;Antoniou;Genet Epidemiol,2000

4. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.;Peto;J Natl Cancer Inst,1999

5. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases.;Br J Cancer,2000

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Testing Uptake among Ovarian Cancer Survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study;Cancers;2024-07-17

2. Cascade genetic testing: an underutilized pathway to equitable cancer care?;Familial Cancer;2024-05-15

3. Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico;International Journal of Gynecologic Cancer;2024-03-06

4. Disparities in genetic testing for breast cancer among black and Hispanic women in the United States;Clinical Imaging;2024-03

5. Germline and somatic testing for ovarian Cancer: An SGO clinical practice statement;Gynecologic Oncology;2024-02